✦ LIBER ✦

Effects of CYP2D6 status on harmaline metabolism, pharmacokinetics and pharmacodynamics, and a pharmacogenetics-based pharmacokinetic model

✍ Scribed by Chao Wu; Xi-Ling Jiang; Hong-Wu Shen; Ai-Ming Yu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of the inhibition of CYP3A4 or CY

✍ Oliver Kummer; Felix Hammann; Claudine Moser; Olivier Schaller; Jürgen Drewe; St 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 196 KB

Pharmacokinetics and QT interval pharmac

✍ Desai, M; Tanus-Santos, J E; Li, L; Gorski, J C; Arefayene, M; Liu, Y; Desta, Z; 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 158 KB

A Meta-Analysis of CYP2D6 Metabolizer Ph

✍ Blake, C M; Kharasch, E D; Schwab, M; Nagele, P 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 370 KB

Impact of CYP2D6 Poor Metabolizer Phenot

✍ Kevin M. Sowinski; Brad S. Burlew 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 523 KB

Modelling the pharmacokinetics of tramad

✍ F. Di Patti; D. Fanelli; R.S. Pedersen; C. Giuliani; F. Torricelli 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 642 KB

The effects of tramadol on static and dy

✍ Frank Fliegert; Burkhard Kurth; Karin Göhler 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 308 KB